P2RX7 and Alzheimer disease: Furthermore, blockade of purinergic receptors P2Y1 was associated with improved cognition in AD models, while P2X7 inhibition was found beneficial in autoimmune disorders, linking eATP and iron to impaired immune tolerance (87, 130, 131).